2024 annual financial data

Keros Therapeutics 2024 Net margin

Direct answer

Net margin was -5,277.55%.

Operating income was -210.83M USD and net income was -187.35M USD.
Operating cash flow was -160.87M USD.

Get free Keros Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
3.55M USD
Operating income
-210.83M USD
Net income
-187.35M USD
Operating cash flow
-160.87M USD